Chlamydia trachomatis and Neisseria gonorrhoeae NA, Liquid Cytology
Hemoglobin Electrophoresis
Mucopolysaccharidosis VI (ARSB) Gene Mutation Analysis
Alpha Globin (HBA1 and HBA2) Gene Analysis
p16 by Immunohistochemistry (CINtec® Histology)
Midazolam, Serum
G6PC (Glucose-6-phosphatase, Catalytic Subunit), Glycogen Storage Disease Type 1 (von Gierke Disease) Gene Mutation Analysis
Chloride, 24 Hour, Urine
Gastrointestinal Parasite Pathogen Panel, Molecular
Follicular Lymphoma, bcl-2/JH t(14;18), FISH
LDS
Sign up
Log in
LDS
/
Medical Tests
/
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test
Interpretation
Access to
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
is restricted.
Sign up now